EX-99.1 2 v378220_ex99-1.htm EXHIBIT 99.1

Sapiens Logo notag.jpg

Sapiens Reports Results for the First Quarter 2014

 

Record Quarterly Revenue of $36.6 Million, Up 16.3% Year-Over-Year

  

 

Holon, Israel, May 12, 2014 – Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announced today its financial results for the first quarter ended March 31, 2014.

 

First Quarter Financial and Business highlights include:

  • Non- GAAP Revenue increased by 16.3% to $36.6 million from the first quarter of 2013
  • Non- GAAP operating profit was $3.7 million compared to $3.4 million in the first quarter of 2013, an increase of 8.9%.
  • Non-GAAP net income attributable to Sapiens' shareholders reached $3.4 million, compared to $3.4 million in the first quarter of 2013.
  • Cash and cash equivalents as of March 31, 2014 was $75.0 million, and Sapiens has no outstanding financial debt.

Roni Al-Dor, President and CEO of Sapiens, commented: "This was a strong start to 2014, with significant growth across all of our products: L&P, P&C and Decision. We continue to gain market share, and are focused on geographic expansion while simultaneously selling deeper into our current customer base.
Over the past few quarters, we have been focused on expanding and enhancing our sales organization to further grow our customer base. We remain excited and confident about our opportunities in 2014 and beyond.”

 

Mr. Al-Dor concluded: "We reiterate our revenue guidance of the range of $154 million to $158 million for the full-year 2014."

 

 
 

 

Quarterly Results Conference Call

 

Sapiens management will host its earnings conference call today, May 12th, 2014 at 10:00 AM EDT, 17:00 Israel, to discuss the results.
To participate in the call, please dial in to the following numbers: United States 1.888.668.9141, International: +972.3.918.0609, UK: 0.800.917.5108 . The call will be webcast live on the Company’s website at http://www.sapiens.com/webcasts-presentations.htm. An online replay will also be available approximately two hours following the call. A telephone replay of the call will be available for 7 days after the live broadcast, and may be accessed by dialing: United States 1.888.295-2634, International +972.3.925 5901.

 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, Non-GAAP gross profit, Non-GAAP operating income, Non-GAAP net income attributed to Sapiens shareholders, Non-GAAP basic and diluted earnings per share.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

 

The Company defines Adjusted EBITDA as net Profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized internal-use software development costs, Amortization of internal-use software development costs interest expense, provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business. The Company uses Adjusted EBITDA as a measurement of its operating performance because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflect an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures provide a more complete understanding of factors and trends affecting its business.

 

 
 

 

Summary of Non-GAAP financial Information

 

    For the three months ended  
   03/31/2014   03/31/2013 
   (unaudited)   (unaudited) 
         
 Revenues  $36,628   $31,507 
 Gross profit   14,648    13,485 
 Operating profit   3,652    3,355 
 Net income attributable to Sapiens' shareholders   3,375    3,372 
 Adjusted EBITDA   4,020    3,617 
 Basic earnings per share   0.07    0.09 
 Diluted earnings per share   0.07    0.08 

 

 

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions for the general insurance, property & casualty, life, pension and annuities markets, and business decision management software, globally. We have a track record of over 30 years in delivering superior software solutions to more than 130 financial services organizations. Our team of more than 900 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com

 

 
 

  

Forward Looking Statement

Some of the statements in this press release may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management’s current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement. These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties as well as certain additional risks that we face, you should refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2013 and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

 

Investors and Media Contact:
Yaffa Cohen-Ifrah

VP Corporate Marketing & Communications

Sapiens International

Office: +972-3-790 2026

e-Mail: yaffa.cohen-ifrah@sapiens.com



 

 
 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

 

   Three months ended 
   March 31, 
   2014   2013 
   (unaudited)   (unaudited) 
         
 Revenue  $36,628   $31,507 
 Cost of revenue   23,251    19,363 
           
 Gross profit   13,377    12,144 
           
 Operating Expenses:          
   Research and development, net   2,889    3,224 
   Selling, marketing, general and administrative   7,314    6,340 
 Total operating expenses   10,203    9,564 
           
 Operating income   3,174    2,580 
           
 Financial income, net   (46)   (285)
 Taxes and other expenses, net   179    275 
           
           
 Net income  $3,041   $2,590 
           
 Attributable to non-controlling interest   19    (43)
           
 Net income attributable to Sapiens' shareholders  $3,022   $2,633 
           
           
 Basic earnings per share  $0.07   $0.07 
           
 Diluted earnings per share  $0.06   $0.06 
           
 Weighted average number of shares          
 outstanding used to compute:          
           
 Basic earnings per share   46,413    38,767 
 Diluted earnings per share   48,493    40,643 

 

 
 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

 

 

   Three months ended 
   03/31/2014   03/31/2013 
         
 GAAP and Non-GAAP revenue  $36,628   $31,507 
           
           
 GAAP gross profit  $13,377   $12,144 
 Amortization of capitalized software   1,047    1,124 
 Amortization of other intangible assets   224    217 
 Non-GAAP gross profit  $14,648   $13,485 
           
           
 GAAP operating income  $3,174   $2,580 
 Gross profit adjustments   1,271    1,341 
 Capitalization of software development   (1,401)   (1,108)
 Amortization of other intangible assets   337    328 
 Stock-based compensation   271    214 
 Non-GAAP operating income  $3,652   $3,355 
           
           
 GAAP net income attributable to Sapiens' shareholders  $3,022   $2,633 
 Operating income adjustments   478    775 
 Other   (125)   (36)
 Non-GAAP net income attributable to Sapiens' shareholders  $3,375   $3,372 
           
           
           
 Non-GAAP basic earnings per share  $0.07   $0.09 
           
 Non-GAAP diluted earnings per share  $0.07   $0.08 

 

 

 

 
 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands

 

   March 31,   December 31, 
   2014   2013 
   (unaudited)   (unaudited) 
         
 ASSETS          
           
 CURRENT ASSETS:          
Cash and cash equivalents  $74,969   $70,313 
Trade receivables, net   24,875    23,669 
 Other receivables and prepaid expenses   4,085    4,126 
 Deferred Taxes   2,389    2,420 
           
 Total current assets   106,318    100,528 
           
 LONG-TERM ASSETS:          
Property and equipment, net   5,403    5,263 
Severance pay fund   11,097    11,228 
Other intangible assets, net   29,642    30,014 
Other long-term assets   2,930    2,957 
Goodwill   72,213    72,438 
           
 Total long-term assets   121,285    121,900 
           
 TOTAL ASSETS  $227,603   $222,428 
           
 LIABILITIES AND EQUITY          
           
 CURRENT LIABILITIES:          
 Trade payables  $4,448   $6,517 
 Accrued expenses and other liabilities   22,931    21,248 
Deferred revenue   12,089    9,928 
           
 Total current liabilities   39,468    37,693 
           
 LONG-TERM LIABILITIES:          
 Other long-term liabilities   1,616    1,712 
 Accrued severance pay   12,447    12,615 
           
 Total long-term liabilities   14,063    14,327 
           
 EQUITY   174,072    170,408 
           
 TOTAL LIABILITIES AND EQUITY  $227,603   $222,428 

 

 

 
 

 

SAPIENS INTERNATIONAL CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. Dollars in thousands

 

 

   For the three months ended 
   03/31/2014   03/31/2013 
   (unaudited)   (unaudited) 
Cash flows from operating activities:          
Net income  $3,041   $2,590 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Depreciation and amortization   1,976    1,931 
Stock-based compensation related to options issued employees   271    214 
increase in trade receivables   (1,172)   (5,670)
Deferred tax assets   (27)   - 
Decrease (Increase) in other operating assets   88    (1,335)
Increase (Decrease) in trade payables   (2,056)   2,963 
Increase  in other operating liabilities   1,738    278 
Increase  in deferred revenues   2,168    2,483 
Severance pay   (31)   32 
Net cash provided by operating activities   5,996    3,486 
           
Cash flows from investing activities:          
Purchase of property and equipment   (511)   (698)
Increase in capitalized software development costs   (1,401)   (1,108)
Increase in Restricted Cash   (57)   (344)
Net cash used in investing activities   (1,969)   (2,150)
           
Cash flows from financing activities:          
Distribution of dividend   -    (5,802)
Proceeds from employee stock options exercised   727    1,145 
Net cash provided by (used in) financing activities   727    (4,657)
           
Effect of exchange rate changes on cash and cash equivalents   (98)   (144)
           
Increase (decrease) in cash and cash equivalents   4,656    (3,465)
Cash and cash equivalents at the beginning of period   70,313    29,050 
           
Cash and cash equivalents at the end of period  $74,969   $25,585